Skip to main content
SpringerLink
Log in

Child with Alterations of Mood

  • Chapter
  • First Online:
Symptom-Based Approach to Pediatric Neurology

  • 789 Accesses

Abstract

Childhood depression is being recognized as a significant co-morbidity in many children with underlying neurological disorders. The symptoms may vary depending on the age of the child and the associated organic disease processes. The primary care physician is in a unique position of having a long-standing rapport with families and therefore may be able to promptly identify children with depression or anxiety. In this chapter, we review the etiology, symptoms, and currently available treatment options for childhood and adolescent depression.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Twenge JM, Cooper AB, Joiner TE, Duffy ME, Binau SG. Age, period, and cohort trends in mood disorder indicators and suicide-related outcomes in a nationally representative dataset, 2005–2017. J Abnorm Psychol. 2019;128(3):185–99.

    Article  Google Scholar 

  2. Miranda DM, Athanasio B, Oliveira AC, Simoes-e-Silva AC. How is COVID-19 pandemic impacting mental health of children and adolescents? Int J Disaster Risk Reduct. 2020;51:101845.

    Article  Google Scholar 

  3. World Health Organization, et al. Mental health atlas. 2017. 2018.

    Google Scholar 

  4. Ollendick TH, Shortt AL, Sander JB. Internalizing disorders of childhood and adolescence. In: Maddux JE, Winstead BA, editors. Psychopathology: foundations for a contemporary understanding. Mahwah: Lawrence Erlbaum Associates; 2005. p. 353–76.

    Google Scholar 

  5. Costello EJ, Erkanli A, Angold A. Is there an epidemic of child or adolescent depression? J Child Psychol Psychiatry. 2006;47:1263–71.

    Google Scholar 

  6. Keenan K, Hipwell A, Duax J, Stouthamer-Loeber M, Loeber R. Phenomenology of depression in young girls. J Am Acad Child Adolesc Psychiatry. 2004;43:1098–106.

    Article  Google Scholar 

  7. Merikangas KR, He JP, Brody D, Fisher PW, Bourdon K, Koretz DS. Prevalence and treatment of mental disorders among US children in the NHANES. Pediatrics. 2010;125:75–81.

    Article  Google Scholar 

  8. Results from the 2007 National Survey on Drug Use and Health: national findings (DHHS publication no. SMA 08–4343, NSDUH series H-34). Rockville: Office of Applied Studies. 2008.

    Google Scholar 

  9. Avenevoli S, Swendse J, He J-P, Burstein M, Merikangas KR. Major depression in the National Comorbidity Survey-Adolescent Supplement: prevalence, correlates, and treatment. J Am Acad Child Adolesc Psychiatry. 2015;54:37–44.

    Article  Google Scholar 

  10. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996;11(Suppl 3):89–95.

    Article  Google Scholar 

  11. Merikangas KR, Cui L, Kattan G, Carlson GA, Youngstromg EA, Angst J. Mania with and without depression in a community sample of US adolescents. Arch Gen Psychiatry. 2012;69:943–51.

    Article  Google Scholar 

  12. Copeland WE, Brotman MA, Costello EJ. Normative irritability in youth: developmental findings from the Great Smoky Mountains study. J Am Acad Child Adolesc Psychiatry. 2015;54:635–42.

    Article  Google Scholar 

  13. Angold A, Costello E. The child and adolescent psychiatric assessment (CAPA). J Am Acad Child Adolesc Psychiatry. 2000;39:39–48.

    Article  CAS  Google Scholar 

  14. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000;157:1552–62.

    Article  CAS  Google Scholar 

  15. Howard DM, Adams MJ, Clarke TK, Hafferty JD, Gibson J, Shirali M, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2018;22:343–52.

    Article  Google Scholar 

  16. Kendall KM, Rees E, Bracher-Smith M, Legge S, Riglin L, Zammit S, et al. Association of rare copy number variants with risk of depression. JAMA Psychiatry. 2019;76:818–25.

    Article  Google Scholar 

  17. Zhang X, Abdellaoui A, Rucker J, de Jong S, Potash MB, Weissman MM, et al. Genome-wide burden of rare short deletions is enriched in major depressive disorder in four cohorts. Biol Psychiatry. 2019;85:1065–73.

    Article  CAS  Google Scholar 

  18. Zuc O, Schaffner SF, Samocha K, Do R, Hechter E, Kathiresa S, et al. Searching for missing heritability: designing rare variant association studies. Proc Natl Acad Sci U S A. 2014;111:E455–64.

    Google Scholar 

  19. Weissman MM, Wolk S, Wickramaratne P, Goldstein RB, Adams P, Greewald S, et al. Arch Gen Psychiatry. 1999;56:794–801.

    Article  CAS  Google Scholar 

  20. Wickramaratne PJ, Weissman MM. Onset of psychopathology in offspring by developmental phase and parental depression. J Am Acad Child Adolesc Psychiatry. 1998;37:933–42.

    Article  CAS  Google Scholar 

  21. Harrington R, Rutter M, Fombone E. Developmental pathways in depression: multiple meanings, antecedents, and endpoints. Dev Psychopathol. 1996;8:601–16.

    Article  Google Scholar 

  22. Harrington R, Rutter M, Weissman M, Fudge H, Groothues C, Bredenkamp D, et al. Psychiatric disorders in the relatives of depressed probands I. Comparison of prepubertal, adolescent and early adult onset cases. J Affect Disord. 1997;42:9–22.

    Article  CAS  Google Scholar 

  23. Jaffee SR, Moffitt TE, Caspi A, Fombonne E, Poulton R, Martin J. Differences in early childhood risk factors for juvenile-onset and adult-onset depression. Arch Gen Psychiatry. 2002;59:215–22.

    Article  Google Scholar 

  24. van Os J, Jones P, Lewis G, Wadsworth M, Murray R. Developmental precursors of affective illness in a general population birth cohort. Arch Gen Psychiatry. 1997;54:625–31.

    Article  Google Scholar 

  25. Ljung T, Chen Q, Lichtenstein P, Larsson H. Common etiological factors of attention-deficit/hyperactivity disorder and suicidal behavior: a population-based study in Sweden. JAMA Psychiatry. 2014;71:958–64.

    Article  Google Scholar 

  26. Nock MK, Green JG, Hwang I, McLaughlin KA, Sampson MA, Zaslavsky AM, et al. Prevalence, correlates, and treatment of lifetime suicidal behavior among adolescents: results for the National Comorbidity Survey Replication Adolescent Supplement. JAMA Psychiatry. 2013;70:3000–310.

    Article  Google Scholar 

  27. Rice F, Riglin L, Thapar AK, Heron J, Anney R, O’Donovan MD, et al. Characterizing developmental trajectories and the role of neuropsychiatric genetic risk variants in early-onset depression. JAMA Psychiatry. 2019;76:306–13.

    Article  Google Scholar 

  28. Cross-Disorder Group of the Psychiatric Genomics Consortium. Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell. 2019;179:1469–82.

    Article  Google Scholar 

  29. Hazell P, Mirzaie M. Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev. 2013;2013:CD002317.

    Google Scholar 

  30. Brainstorm Consortium. Analysis of shared heritability in common disorders of the brain. Science. 2018;360(6395):eaap8757.

    Article  Google Scholar 

  31. Strober M, Carlson G. Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation. Arch Gen Psychiatry. 1982;39:549–55.

    Article  CAS  Google Scholar 

  32. Axelson D, Birmaher B, Strober M, et al. Course of subthreshold bipolar disorder in youth: diagnostic progression from bipolar disorder not otherwise specified. J Am Acad Child Adolesc Psychiatry. 2011;50:1001–16.

    Article  Google Scholar 

  33. DelBello MP. A risk calculator for bipolar disorder in youth: improving the odds for personalized prevention and early intervention? J Am Acad Child Adolesc Psychiatry. 2018;57(10):725–7.

    Article  Google Scholar 

  34. Lewis K, Mars B, Lewis G, Rice F, Sellers R, Thapar A, Craddock N, Collishaw S, Thepar A. Do parents know best? Parent-reported vs. child-reported depression symptoms as predictors of future child mood disorder in a high-risk sample. J Affect Disord. 2012;141(2–3, 233):–236.

    Google Scholar 

  35. Klaus NM, Mobilio A, King CA. Parent-adolescent agreement concerning adolescents’ suicidal thoughts and behaviors. J Clin Child Adolesc Psychol. 2009;38(2):245–55.

    Article  Google Scholar 

  36. Erensoy H. The association between anxiety and depression with 25(OH)D and thyroid stimulating hormone levels. Neuroscience (Riyadh). 2019;24(4):290–5.

    Article  Google Scholar 

  37. Kazdin AE, Weisz JR. Identifying and developing empirically supported child and adolescent treatments. J Consult Clin Psychol. 1988;66(1):19–36.

    Article  Google Scholar 

  38. Garber J, Clarke GN, Weersing VR, Beardslee WR, Brent DA, Gladstone TRG, et al. Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA. 2009;301(21):2215–24.

    Article  CAS  Google Scholar 

  39. Dwyer JB, Bloch MH. Antidepressants for pediatric patients. Curr Psychiatr. 2019;18:26–42F.

    Google Scholar 

  40. Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry. 2009;48(7):721–9.

    Article  Google Scholar 

  41. Findling RL, Robb A, Bose A. Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial. J Child Adolesc Psychopharmacol. 2013;23(7):468–80.

    Article  Google Scholar 

  42. Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, Greenbaum MS, et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA. 2003;290(8):1033–41.

    Article  CAS  Google Scholar 

  43. Brent D, Emslie G, Clarke G, Wanger K, Asarnow JR, Keller M, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008;299(8):901–13.

    Article  CAS  Google Scholar 

  44. Compton SN, Grant PJ, Chrisman AK, Gammon PJ, Brown VL, March JS. Sertraline in children and adolescents with social anxiety disorder: an open trial. J Am Acad Child Adolesc Psychiatry. 2001;40(5):564–71.

    Article  CAS  Google Scholar 

  45. Emslie GJ, Prakash A, Zhang Q, Pangallo BA, Bangs ME, March JS. A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder. J Child Adolesc Psychopharmacol. 2014;24(4):170–9.

    Article  CAS  Google Scholar 

  46. Haapasalo-Pesu K, Vuola T, Lahelma L, Marttunen M. Mirtazapine in the treatment of adolescents with major depression: an open-label, multicenter pilot study. J Child Adolesc Psychopharmacol. 2004;14(2):175–84.

    Article  Google Scholar 

  47. Rush AJ, Warden D, Wisniewski SR, et al. STAR*D: revising conventional wisdom. CNS Drugs. 2009;23(8):627–47.

    Google Scholar 

  48. Shon S, Joo Y, Lee J, Kim H. Lamotrigine treatment of adolescents with unipolar and bipolar depression: a retrospective chart review. J Child Adolesc Psychopharmacol. 2014;24(5):258–87.

    Article  Google Scholar 

  49. Amerio A, Ossola P, Scagnelli F, Odone A, Allinovi M, Cavalli A, et al. Safety and efficacy of lithium in children and adolescents: a systematic review in bipolar illness. Eur Psychiatry. 2018;54:85–97.

    Article  CAS  Google Scholar 

  50. Dwyer JB, Stringaris A, Brent DA, Bloch MH. Annual research review: defining and treating pediatric treatment-resistant depression. J Child Psychol Psychiatry. 2020;61(3):312–32.

    Article  Google Scholar 

  51. March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: treatment for adolescents with depression study (TADS) randomized controlled trial. JAMA. 2004;292(7):807–20.

    Article  CAS  Google Scholar 

  52. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63(3):332–9.

    Article  CAS  Google Scholar 

  53. Morrato EH, Libby AM, Orton HD, deGruy FV, Brent DA, Allen R, et al. Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry. 2008;165:42–50.

    Article  Google Scholar 

  54. Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry. 2007;164:884–91.

    Article  Google Scholar 

  55. Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkins JA, et al. Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry. 2007;164:1356–63.

    Article  Google Scholar 

  56. Ong SH, Wickramaratne P, Tang M, Weissman MM. Early childhood sleep and eating problems as predictors of adolescent and adult mood and anxiety disorders. J Affect Disord. 2006;96(1–2):1–8.

    Article  Google Scholar 

  57. Dahl RE, Ryan ND, Birmaher B, al-Shabbout M, Williamson DE, Kupfer DJ. Sleep onset abnormalities in depressed adolescents. Biol Psychiatry. 1996;39(6):400–10.

    Article  CAS  Google Scholar 

  58. Emslie GJ, Rush AJ, Weinberg WA, Rintelman JW, Roffwarg HP. Sleep EEG features of adolescents with major depression. Biol Psychiatry. 1994;36(9):573–81.

    Article  CAS  Google Scholar 

  59. Boaffo A, Greenham S, Sullivan M, Bazaid K, Suntharalingam S, Silbernagel L, et al. Medications for sleep disturbance in children and adolescents with depression: a survey of Canadian child and adolescent psychiatrists. Child Adolesc Psychiatry Ment Health. 2020;14:10.

    Article  Google Scholar 

  60. Kennard BD, Mayes TL, Chahal Z, Nakonezny PA, Moorehead A, Emslie GJ. Predictors and moderators of relapse in children and adolescents with major depressive disorder. J Clin Psychiatry. 2018;79(2):15m10330.

    Article  Google Scholar 

  61. Youngstedt SD. Effects of exercise on sleep. Clin Sports Med. 2005;24(2):355–65.

    Article  Google Scholar 

  62. Dopp RR, Mooney AJ, Armitage R, King C. Exercise for adolescents with depressive disorders: a feasibility study. Depress Res Treat. 2012;2012:257472.

    Google Scholar 

  63. Dopp R, Miklja Z, Jurries E, Mooney A. Exercise in adolescent depression: fitness, clinical outcomes, and BDNF. J Neurol Neurobiol. 2020;6(3).

    Google Scholar 

  64. Ginsburg GS, Silva SG, Jacobs RH, Tonev S, Hoyle RH, Kingery JN, Reinecke MA, Curry JF, March JS. Cognitive measures of adolescent depression: unique or unitary constructs? J Clin Child Adolesc Psychol. 2009;38(6):790–802.

    Article  Google Scholar 

  65. Lohoff FW. Overview of the genetics of major depressive disorder. Curr Psychiatry Rep. 2010;12(6):539–46.

    Article  Google Scholar 

  66. Sander JB, McCarty CA. Youth depression in the family context: familial risk factors and models of treatment. Clin Child Fam Psychol Rev. 2005;8(3):203–19.

    Article  Google Scholar 

  67. Auerbach RP, Admon R, Pizzagalli DA. Adolescent depression: stress and reward dysfunction. Harv Rev Psychiatry. 2014;22(3):139–48.

    Article  Google Scholar 

  68. Chun T, Mace S, Katz E. Evaluation and management of children and adolescents with acute mental health and/or behavioral emergencies. Pediatrics. 2016;138(3).

    Google Scholar 

  69. Posner K, Melvin GA, Stanley B, Oquendo MA, Gould M. Factors in the assessment of suicidality in youth. CNS Spectr. 2007;12(2):156–62.

    Article  Google Scholar 

  70. Janiri D, Doucet GE, Pompili M, Sani G, Luna B, Brent DA, Frangou S. Risk and protective factors for childhood suicidality: a US population-based study. Lancet Psychiatry. 2020;7(4):317–26.

    Article  Google Scholar 

  71. Shain B, Committee on Adolescence. Suicide and Suicide attempts in adolescents. Pediatrics. 2016;138(1):e20161420.

    Article  Google Scholar 

  72. Oberle E, Schonert-Reicht KA. Social and emotional learning: recent research and practical strategies for promoting children’s social and emotional competence in schools. In: Matson J, editor. Handbook of social behavior and skills in children. Autism and child psychopathology series. Cham: Springer. 2003. p. 175–197.

    Google Scholar 

  73. Beardslee WR, Versage EM, Van de Velde P, Swatlin S, Hoke L. Preventing depression in children through resiliency promotion: the prevention intervention project. In: McMahon RJ, Peters R, editors. The effects of parental dysfunction on children. New York: Kluwer Academic/Plenum; 2003. p. 71–86.

    Google Scholar 

  74. Clark GN, Hornbrook M, Lynch F, Polen M, Gale J, Beardslee W, O’Connor E, Seeley J. A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Arch Gen Psychiatry. 2001;58(12):1127–34.

    Article  Google Scholar 

  75. Brent DA, Birmaher B, Kolko D, Baughter M, Bridge J. Subsyndromal depression in adolescents after a brief psychotherapy trial: course and outcome. J Affect Disord. 2001;63(1–3):51–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA

    Richard Dopp, Priyanka Reddy & Gregory Hanna

Authors
  1. Richard Dopp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Priyanka Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gregory Hanna
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard Dopp .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, University of Texas Health Science Center, San Antonio, TX, USA

    Deepak M. Kamat

  2. Pediatrics and Neurology, Central Michigan University Children’s Hospital of Michigan, Detroit, MI, USA

    Lalitha Sivaswamy

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dopp, R., Reddy, P., Hanna, G. (2022). Child with Alterations of Mood. In: Kamat, D.M., Sivaswamy, L. (eds) Symptom-Based Approach to Pediatric Neurology . Springer, Cham. https://doi.org/10.1007/978-3-031-10494-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-10494-7_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-10493-0

  • Online ISBN: 978-3-031-10494-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation